Literature DB >> 9730300

Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients.

A Barzilai1, B Rubinovich, D Blank-Porat, E Rubinstein, N Keller, I Levi.   

Abstract

Mycobacterium simiae is rarely isolated in clinical settings of non-HIV-infected patients. Isolation of M. simiae from clinical specimens in clusters has been limited to some parts of the world that include Israel, Cuba and the southern USA, mainly Texas. Only 8 patients with HIV and disseminated M. simiae infection have been previously described in the English literature. Successful treatment of disseminated M. simiae infection has never been reported and 6 of the cases have died within 8 months of diagnosis. We reviewed retrospectively the medical records of HIV-infected patients who had positive blood or bone marrow cultures for M. simiae at the Sheba Medical Center, Tel-Hashomer, Israel, between January 1992 and December 1996. A case of disseminated M. simiae infection was defined as isolation of M. simiae in blood or bone marrow culture in an HIV-infected patient with a compatible, otherwise unexplained, systemic disease. Mycobacterium simiae was isolated in blood and/or bone marrow cultures from 3 HIV-infected patients during the last 5 y. We describe the first successful treatment in AIDS patients with disseminated M. simiae infection. The patients are alive and well 20 months after instituting a combination of 3 antimycobacterial agents, clarithromycin, ethambutol and ciprofloxacin and intensive antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730300     DOI: 10.1080/003655498750003528

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  5 in total

1.  Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.

Authors:  M H Cynamon; J L Carter; C M Shoen
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  Pulmonary Mycobacterium simiae infection: comparison with pulmonary tuberculosis.

Authors:  C Maoz; D Shitrit; Z Samra; N Peled; L Kaufman; M R Kramer; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-17       Impact factor: 3.267

3.  Mycobacterium simiae: Harmless colonizer or deadly pathogen?

Authors:  Jean-Francois Jabbour; Amal Hamieh; Sima L Sharara; Souha S Kanj
Journal:  PLoS Pathog       Date:  2020-04-30       Impact factor: 6.823

4.  Iatrogenic Mycobacterium simiae skin infection in an immunocompetent patient.

Authors:  Jaime Piquero; Vanesa Piquero Casals; Edgar Larotta Higuera; Mitchell Yakrus; David Sikes; Jacobus H de Waard
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

5.  Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel.

Authors:  Isaac Levy; Galia Grisaru-Soen; Liat Lerner-Geva; Eitan Kerem; Hana Blau; Lea Bentur; Micha Aviram; Joseph Rivlin; Elie Picard; Anita Lavy; Yakov Yahav; Galia Rahav
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.